CellzDirect, Inc. enters into 5 year exclusive partnership with Advanced Pharmaceutical Sciences, Inc.
Press Release, September 14, 2006
CellzDirect Inc. (CDI), a global leader in hepatic cell products and in vitro contract services, has entered into a long-term, exclusive strategic partnership with Advanced Pharmaceutical Sciences, Inc. (APS). Under the agreement, APS will focus exclusively on producing cryopreserved human hepatocytes to supplement CellzDirect’s hepatic products inventory. CellzDirect will serve as an exclusive distributor for APS’s new medium for thawing cryopreserved hepatocytes (cryopreserved hepatocyte recovery medium) which, when used with the CDI/APS cryopreserved hepatocytes, yield cells with high viability and attachment efficiency.
The goal of the collaboration is to meet the growing demand for high-quality cryopreserved human hepatocytes, especially “attachable” cryopreserved human hepatocytes needed for enzyme induction, drug transporter, and in vitro hepatotoxicity screening studies in the pharmaceutical industry. The FDA recently accepted the use of attachable cryopreserved human hepatocytes for use in enzyme induction drug-drug interaction studies.
APS is headed by President and CEO Dr. Albert P. Li, a leading researcher and pioneer in hepatocyte isolation and cryopreservation.
“We are thrilled to partner with Dr. Li and his team at APS,” said Scott Edelman, President and CEO of CellzDirect, Inc. “Our combined scientific expertise with hepatocytes and strong commitment to making highquality human hepatocytes more readily available promises to have a profound affect on in vitro research.”
“We are extremely excited about our new technologies that allow us to routinely produce cryopreserved hepatocytes with the attachment efficiency, morphology, and biochemical properties of freshly isolated cells,” said Dr. Li. “The quality of our new cryopreserved human hepatocyte lots is already being touted as the new standard for industry. The partnership with CellzDirect will allow us to provide these pristine cells to researchers around the world.”
For more information on cryopreserved and other hepatic products, contact CellzDirect’s sales team at 1-866-95-CELLZ (1-866-952-3559), or stop by the CellDirect booth at the upcoming International Society for the Study of Xenobiotics (ISSX) in Puerto Rico on October 23-26.
About CellzDirect: CellzDirect, Inc., is a privately held bioscience company that provides bio-pharmaceutical companies with quality cell products and contract laboratory services focused primarily on drug metabolism and toxicology. With CellzDirect’s support, scientists are better able to conduct research that accelerates the discovery of safe and effective drugs.
For further information about CellzDirect, please contact:
Shiloh Barfield, Director of Sales and Marketing, CellzDirect, Inc.
Ph: (919) 545-9959
Email: shilohb@cellzdirect.com
<< current news
